Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like What You Need to Know About Corbin Therapeutics January 14, 2018 <b>eSight</b> 3 Launches In Europe June 22, 2017 4 Small Biotech M&A Targets for Gilead February 14, 2018